Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Pediatric Patients Diagnosed With Type 1 Diabetes Mellitus

NCT06129448 is registered in ClinicalTrials.gov with Sirnak State Hospital as lead sponsor.

NCT NCT06129448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06129448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Pediatric Patients Diagnosed With Type 1 Diabetes Mellitus
Lead sponsor
Sirnak State Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2023
Completion date
February 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diastolic dysfunction, systolic dysfunction